deltatrials
Completed NA NCT00005892

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

Sponsor: Fairview University Medical Center

Conditions Fanconi's Anemia Leukemia, Lymphocytic, Acute Leukemia, Nonlymphocytic, Acute Myelodysplastic Syndromes
Interventions Allogeneic Bone Marrow Transplantation cyclophosphamide
Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Mar 31, 2000

This NA trial investigates Fanconi's Anemia and Leukemia, Lymphocytic, Acute and is currently completed. Fairview University Medical Center leads this study, which shows 5 recorded versions since 2000 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Mar 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fairview University Medical Center
Data source: Office of Rare Diseases (ORD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Minneapolis, United States